SOURCE: BioMedReports

BioMedReports

April 28, 2011 08:22 ET

Report: Northwest Biotherapeutics Won't Be Staying Under the Radar for Long

LOS ANGELES, CA--(Marketwire - Apr 28, 2011) - Important news developments may be brewing at Northwest Biotherapeutics (OTCBB: NWBO).

A special report on the company and some news involving NWBO's clinical trials of DCVax® for GBM brain cancer is now available at:

http://biomedreports.com/2011042866336/northwest-biotherapeutics-wont-be-staying-under-the-radar-for-long.html

In addition, investors interested in accessing BioMedReports' new complete database of clinical trials and upcoming FDA and world-wide regulatory decisions can go to:

http://biomedreports.com/access-our-exclusive-fda-and-clinical-trials-calendars.html

News developments and live healthcare sector updates are available constantly via twitter at: http://twitter.com/BioMedReports

About BioMedReports.Com

BioMedReports is a news portal covering the biomedical news and financial sector. BioMedReports is not paid or compensated to report the news and developments of publicly traded companies in the healthcare sector of the markets.

Full disclosures and information about the stocks are available at BioMedReports.Com

Contact Information

  • Media Contacts Only:

    Mary Davila
    Assistant Editor
    BioMedReports.Com
    e-mail: Email Contact
    Tel: +1 323 472 4480
    Fax: +1 888 210 3556